Singh Shawn 4
4 · VistaGen Therapeutics, Inc. · Filed Jul 2, 2021
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Common Stock
2021-06-30$1.95/sh+5,000$9,733→ 45,375 total
Holdings
- 26,234(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan on June 30, 2021 in a transaction exempt under Rule 16b-3(c).